/second, which significantly increased 6 months after GKS and continued to increase with time (p = 0.0086). The mean ADC value for treated solid tumors as of the last mean follow-up of 36 months (range 18-60 months) was 1.72 ± 0.26 × 10 -3 mm 2 /second (range 1.50-2.09 × 10 -3 mm 2 /second), which was significantly higher than that before GKS (p = 0.0001). Tumor volumes were positively related to ADC values (p = 0.03).
The mean ADC value before GKS for all cystic VSs was 2.09 ± 0.24 × 10 -3 mm 2 /second (range 1.80-2.58 × 10 -3 mm 2 /second). The mean ADC value for treated cystic tumors as of the last mean follow-up of 38 months (range 18-48 months) was 1.89 ± 0.22 × 10 -3 mm 2 /second. In 3 patients harboring solid VSs, the tumor enlarged after GKS but the ADC values were higher than those before GKS. The authors considered these tumors to be controlled and continued follow-up in the patients.
Conclusions. Apparent diffusion coefficient values may be useful for evaluating treatment results before any definite volume change is detected on imaging studies and for distinguishing radiation-induced necrosis from tumor recurrence in cases in which other imaging results are not definitive, as in cases of increased tumor volume or no volume change. The authors suggest that ADC measurements be included during routine MR imaging examinations for the evaluation of GKS results. absorption of cellular debris. 3 An examination of the literature shows that the tumor control rate for VSs treated with GKS is greater than 90%, but a significant proportion of these tumors (19.6%-51%) display no change in size. 6, 8, 13 Even though no change in tumor size throughout long-term follow-up is also considered successful tumor control, it is likely that the cellularity of the tumor has already been altered after treatment.
Cellularity and the integrity of cellular membranes that impede water translational mobility can affect the diffusion of water within tumor tissues. Diffusionweighted imaging with echo-planar sequences can be used to differentiate various brain tumors, 9, 12, 14, 16 but it is rarely used to evaluate tumor responses after treatment. 4, 7 There have been no reports on changes in VSs after GKS. The purpose of this study was to investigate the clinical usefulness of ADC values for evaluating VSs and to assess the correlation of DW imaging measurements with radiosurgical effects on the tumors.
Methods

Patient Population
From January 2004 to December 2008, we conducted a prospective trial in 31 patients who harbored solid (24 patients) or cystic (7 patients) VSs and were treated by GKS performed with a 201-cobalt source at our Gamma Knife Center. The study was approved by the local ethics committee, and informed consent was obtained from the patients. Routine MR imaging sessions, in which DW images and ADC measurements for the VSs were obtained, were regularly scheduled before GKS and at 6-month intervals following GKS.
The clinical data obtained in the 31 patients are shown in Table 1 .
Following administration of a local anesthetic agent supplemented with a sedative, each patient's head was fitted with a Leksell model G stereotactic coordinate frame (Elekta Instruments). High-resolution contrast-enhanced MR imaging was performed to determine tumor location. The GammaPlan dose-planning system (Elekta) was used to determine dosimetry with multiple isocenters. In this study the mean tumor volume was 8.2 cm 3 (range 1-24 cm 3 ), and the mean tumor margin dose was 12 Gy (range 11-13 Gy).
Apparent Diffusion Coefficients
Magnetic resonance images were obtained in all patients by using a 1.5-T scanner (Signa Horizon LX2, GE Medical Systems). The manufacturer-supplied birdcage 8-channel neurovascular coil was used to detect signals during conventional MR and DW imaging. The DW imaging parameters were as follows: TE 95 msec; TR 10,000 msec; matrix size 128 × 128; FOV 300 mm; slice thickness 5.5 mm; NEX 1. Diffusion was measured in 3 directions (along the x, y, and z axes), with a b value of 1000 seconds/mm 2 for each direction. In addition, an image without diffusion gradients was acquired. The total acquisition time for all images with various diffusion sensitivities was 40 seconds. To minimize the effect of diffusion anisotropy, an average of the values obtained for the 3 diffusion directions was calculated to provide the trace of the diffusion tensor.
Analysis of the MR Imaging Data
Image postprocessing was performed using a workstation running vendor-provided software (Advantage 4.0 and FuncTool, respectively; GE Medical Systems). These software programs enable visualization and processing of DW imaging data. We created maps of the ADC values by performing calculations on a pixel-by-pixel basis. Data were analyzed using a t-test to compare the mean ADC values obtained before GKS with those obtained after GKS. A p value < 0.05 was considered statistically significant.
Results
Magnetic Resonance Imaging
The mean follow-up period in this study was 36.5 months (range 18-60 months). Imaging studies demonstrated a reduction in tumor volume in 19 patients (61.3%) and tumor growth arrest in 9 patients (29%) ( Table 1) . There was tumor enlargement at 18, 36, and 42 months in the remaining 3 patients (9.7%). Imaging studies revealed a loss of central enhancement of the tumor in 28 patients (90.3%). The volume of central necrosis paralleled the reduction in tumor size.
Apparent Diffusion Coefficients
The mean ADC value for all solid VSs was 1.06 ± 0.17 × 10 -3 mm 2 /second (range 0.97-1.27 × 10 -3 mm 2 /second). This value significantly increased 6 months after GKS to 1.57 ± 0.2 × 10 -3 mm 2 /second and continued to increase with time (p = 0.0086). The mean ADC value for treated solid VSs as of the last follow-up (mean 36 months, range 18-60 months) was 1.72 ± 0.26 × 10 -3 mm 2 / second, which was significantly higher than the value obtained before GKS (p = 0.0001) (Fig. 1) . Tumor volumes were positively related to ADC values (p = 0.03). Changes in ADC values for the 24 solid VSs ranged from 26% to 90% (mean 48% ± 17%), and changes in ADC values for the 7 cystic VSs ranged from -32% to 17% (mean -13% ± 16.7%) (Fig. 2) . In 3 patients who harbored solid VSs, the tumor enlarged after GKS, but the ADC values were higher than those measured before GKS. We considered these tumors to be controlled and continued follow-up in these 3 patients (Fig. 3) .
The mean ADC value for all cystic VSs before GKS was 2.09 ± 0.24 × 10 -3 mm 2 /second (range 1.80-2.58 × 10 -3 mm 2 /second). The mean ADC value for treated cystic VSs as of the last mean follow-up of 38 months (range 18-48 months) was 1.89 ± 0.22 × 10 -3 mm 2 /second, which showed a tendency to decrease compared with that before GKS (p = 0.129) (Fig. 4) . The pre-GKS ADC values for cystic tumors were significantly higher than those for solid tumors (p < 0.001), and the downward trend in cystic tumor values also differed from the upward trend in solid tumor values after GKS. Changes in ADC values ranged from +17% to -32% (mean -8.4%) (Fig. 2) .
With regard to changes in tumor volumes, the mean ADC values were as follows: tumor-volume reduction group, 1 
Discussion
Changes in ADCs for VSs After GKS
We found that ADCs for solid VSs were relatively higher than ADCs for normal parenchyma or meningiomas-a finding that has also been noted in other studies.
14,15, 17 The high ADC values for the VSs were consistent with relatively low nucleus-to-cytoplasm ratios and increased diffusion rates, indicating the presence of increased amounts of extracellular water (relatively loose tissue) within the tumor matrix.
14 Histological characteristics may explain these findings, because schwannomas comprise Antoni Type A and Type B neurinomas, and their higher ADCs may reflect the lower cell density of Antoni Type B neurinomas. A subgroup of our patient with cystic schwannomas had significantly high ADC levels, which reflect the tumor's fluid component with a high velocity of water molecules.
After GKS, the ADC values for solid VSs significantly increased from the first follow-up at 6 months and continued to display an upward trend at later followups. Routine MR images showed that most tumors had a loss of central enhancement, but their sizes remained the same or even increased temporarily at some point. Examination of signal intensity on DW images and measurements of ADCs may be useful for monitoring responses after treatment, particularly prior to any change in tumor volume. Other treatments such as chemotherapy, radiotherapy, antigene therapy, or a combination of these treatment modalities may significantly alter the tissue structure of a tumor; therefore, use of ADCs to monitor the cytotoxic response of a tumor to treatment has been recognized in some studies. 3, 7 Use of these therapies consistently leads to increased water diffusion within the tumor, demonstrating a favorable response to treatment. Concordantly, our studies on patients with VSs treated with GKS showed similar diffusion behavior, suggesting a useful application of MR imaging in patients with VSs following GKS. The radiological effect on schwannomas and other benign neoplasms is a combination of both cytotoxic and delayed vascular effects. Linskey et al. 11 grafted human VSs into the subrenal capsule of nude mice and stated that a reduction in tumor size was due to neoplastic cell death after radiosurgery. We believe the effects of GKS are partly caused by radiation-induced apoptosis or necrosis, especially in treatments in which a low radiation dose is used.
The ADC values for cystic VSs were higher than those for solid tumors, because in the former there was free movement of water molecules. Changes in ADC values for cystic tumors after GKS were opposite those for solid tumors-in all but 1 case there was a trend toward decreased values due to the diminishing cystic component as the tumor shrank.
Clinical Application and Limitation of Changes in ADCs
In this study, ADC values of solid tumors significantly increased, even before a change in tumor volume was evident. In a previous study 5 we demonstrated that ADC changes occurred in cases of metastatic tumors as early as 7 days and in cases of meningioma at 30 days after GKS. The rate of change in ADC values in cases of VS needs further intensive study. Nevertheless, we can say that ADC changes precede the real change in tumor size detected on routine follow-up MR images.
In 1 patient with a cystic tumor, the solid portion of the tumor enlarged while the ADC values remained high. Although a recurrence was suspected in this case, we considered the findings to be an effect of radiation; later follow-up proved that treatment had been successful and resulted in remarkable tumor shrinkage (Fig. 4) .
At the last follow-up, images in 3 patients showed tumor enlargement. Although we classified these cases as enlarged tumors, the ADC values remained high, and hence, we considered the findings to be radiation-induced effects rather than tumor recurrence. The follow-up period in these 3 patients ranged from 18 to 48 months. For patients with late or temporarily swelling tumors, ADCs may be good indicators to differentiate tumor recurrence from enlargement due to a radiation effect.
Diffusion-weighted imaging of the entire brain can be completed in 3 seconds or in 48 seconds when 7 different diffusion sensitivities (maximum b = 1000 seconds/ mm 2 ) are used. Our study demonstrates the feasibility of performing serial DW imaging for the clinical management of patients with brain tumors.
Values of ADCs can be affected by metal; the lack of magnetic properties of titanium makes it a better choice for the fixation of bone flaps or dental prostheses. The presence of osseous structures near tumors can also cause blurred MR images, but the use of more contemporary high-field Tesla technology may overcome this defect. Because free water mobility increases greatly and extensively relative to tumor cells, more regions of interest can occur, and consequently, the standard deviations of ADCs can be affected. A new generation of software, however, will allow more precise measurements within smaller voxel volumes. We examined moderate or large tumors in this study, because in cases of small tumors, the osseous component of the skull base is an obstacle for DW imaging. We suggest that DW imaging and ADC measurements be included in routine MR imaging examinations to provide additional information to differentiate tumor responses and to help evaluate equivocal MR imaging findings. This study does not show the proliferative potential of remaining tumor cells, which may be independent of water. Therefore, MR spectroscopy, which provides insight into tumor metabolites, may be applied to further enhance the evaluation of the tumor response to treatment.
Measurement of ADCs may be useful for evaluating treatment results before any definite volume change is noted on imaging studies and to distinguish a radiation effect from a tumor recurrence in cases in which imaging studies are not definitive, as in some patients with increased tumor volumes or no volume change. We suggest that ADC measurements be included in routine MR imaging examinations for the evaluation of GKS results. 
